Innoviva (INVA) FCF Margin (2011 - 2026)

Innoviva (INVA) posted FCF Margin of 35.5% for Q1 2026, down 25.45% on a QoQ basis from 47.62% in Q3 2025, and down 1935.0% year-over-year from 1.93% in Q1 2025.

Innoviva (INVA) FCF Margin (2011 - 2026) Analysis & Trends

Innoviva's FCF Margin history runs 16 years deep, the most recent figure standing at 35.5% for Q1 2026.

  • Quarterly FCF Margin fell 1935.0% year-over-year to 35.5% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 44.38% (down 413.0% YoY) and the FY2025 annual result came in at 47.6%, down 493.0% from the prior year.
  • FCF Margin was 35.5% for Q1 2026 at Innoviva, down from 47.62% in the prior quarter.
  • Across five years, FCF Margin topped out at 4408.67% in Q1 2022 and bottomed at 35.5% in Q1 2026.
  • A 5-year average of 842.44% and a median of 54.85% in 2025 frame the typical range for FCF Margin.
  • Annual changes were most pronounced in 2023 — FCF Margin slumped 301988 bps — and 2024, when it jumped 9665 bps.
  • Innoviva's FCF Margin stood at 72.61% in 2022, then slumped by 34 bps to 47.88% in 2023, then climbed by 1 bps to 48.4% in 2024, then slipped by 2 bps to 47.62% in 2025, then fell by 25 bps to 35.5% in 2026.
  • Business Quant data shows INVA's FCF Margin at 35.5% in Q1 2026, 47.62% in Q3 2025, and 43.95% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 10.45%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 43.35%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.53%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Innoviva 1.57 Bn 969.11 Mn 75.83 Mn 35.50%

Historic Data

Download Data
DateValue
Mar 31, 2026 35.50%
Sep 30, 2025 47.62%
Jun 30, 2025 43.95%
Mar 31, 2025 54.85%
Sep 30, 2024 48.40%
Jun 30, 2024 43.76%
Mar 31, 2024 1,485.45%
Sep 30, 2023 47.88%
Jun 30, 2023 1,350.62%
Mar 31, 2023 1,388.79%
Sep 30, 2022 72.61%
Jun 30, 2022 1,923.61%
Mar 31, 2022 4,408.67%
Sep 30, 2021 93.40%
Jun 30, 2021 3,090.36%
Mar 31, 2021 5,357.13%
Dec 31, 2020 16,920.63%
Sep 30, 2020 84.06%
Jun 30, 2020 101.07%
Mar 31, 2020 93.38%